Litcius/Paper detail

Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study

Susana Monge, Ayelén Rojas‐Benedicto, Carmen Olmedo, Clara Mazagatos, María José Sierra, Aurora Limia, Elisa Martín‐Merino, Amparo Larrauri, Miguel A. Hernán, David Moreno, Manuel Méndez Díaz, Ismael Huerta-González, Antònia Galmés Truyols, Ana Barreno Estévez, Valvanuz García Velasco, Ma Jesús Rodríguez Recio, José Gimeno Sacristán, Montserrat Martínez Marcos, Eliseo Pastor Villalba, María José Macías Ortiz, Ana García Vallejo, Amaya Sánchez Gómez, Rocío García-Pina, Aurelio Barricarte Gurea, Rosa Sancho Martínez, Eva Martínez Ochoa, Mauricio Vázquez Cantero, Atanasio Gómez Anés, María Jesús Pareja Megía, Yolanda Castán, Manuel Roberto Fonseca Álvarez, Antonia Salvà Fiol, Hilda Sánchez Janáriz, Luz López Arce, María Ángeles Cisneros Martín, Frederic Jose Gibernau, Cesar Fernandez Buey, Katja Villatoro Bongiorno, Francisco Javier Rubio García, Fernando Santos Guerra, Jenaro Astray Mochales, Francisco Javier Francisco Verdu, Isabel García Romero, Rosa Oriza Bernal, Tomás Gómez Pérez, Salomé Hijano Villegas, Sergio Román Soto, Diana Gómez‐Barroso, María Fé Lapeña, Virgilio Yagüe Galaup, Mercedes Alfaro Latorre, Marta Aguilera Guzmán, Belén Crespo Sánchez-Eznarriaga, Montserrat Neira León, Noemí Cívicos Villa

2022The Lancet Infectious Diseases84 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBooster (rocketry)VaccinationCohortVaccination scheduleBooster dosePopulationVaccine efficacyCohort studyPediatricsImmunologyInternal medicineEnvironmental healthImmunizationImmune systemAstronomyPhysicsSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingAnimal Virus Infections Studies